Table 5.
Molecular Characterization of MRSA Isolated from Canines Arriving to the Small Animal Hospital in The Ohio State University Veterinary Medical Center during the MRSA Active Surveillance
| |
By canine (total n=24)a |
By isolate (total n=37) |
||
|---|---|---|---|---|
| Canine | MRSA | % | MRSA | % |
| SCCmec typing | ||||
| Type II | 20/24 | 83.3% | 32/37 | 86.5% |
| Type IV | 3/24 | 12.5% | 3/37 | 8.1% |
| No type2 | 2/24 | 8.3% | 2/37 | 5.4% |
| PFGE | ||||
| USA 100 | 20/24 | 83.3% | 32/37 | 86.5% |
| USA 500 | 1/24 | 4.2% | 1/37 | 2.7% |
| USA 800 | 2/24 | 8.3% | 2/37 | 5.4% |
| No type3 | 1/24 | 4.2% | 2/37 | 5.4% |
a
Isolate from one canine was lost before phenotypic and genotypic characterization was performed
b
Not typeable following protocol by Milhierico et al. (2007).
c
Band pattern did not match with any USA type.
MRSA, methicillin-resistant Staphylococcus aureus; PFGE, pulsed-field gel electrophoresis.